Idarucizumab to revert the anticoagulant effect of dabigatran in traumatic acute subdural haematoma: a case report of first use in Latin America

BACKGROUND : Direct oral anticoagulants (DOAC) are an attractive alternative over vitamin K antagonists. They have several advantages in primary and secondary prevention of thromboembolisms due to atrial fibrillation, as well as in prevention and treatment of thromboembolic venous disease. They have...

Descripción completa

Detalles Bibliográficos
Autores principales: Izaguirre Ávila, Raúl, Bahena López, José Eduardo, Cortina de la Rosa, Evelyn, Hernández Márquez, Miguel Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601192/
https://www.ncbi.nlm.nih.gov/pubmed/31449648
http://dx.doi.org/10.1093/ehjcr/ytz098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601192/
https://www.ncbi.nlm.nih.gov/pubmed/31449648
http://dx.doi.org/10.1093/ehjcr/ytz098

Ejemplares similares